Gradually winding down on here - site is increasingly unusable. Transitioning to the other place with the same address. Trying to follow as many as possible from here before going
๐ฃ๐ฟ๐ฒ๐๐๐๐ฟ๐ฒ? ๐ช๐ต๐ฎ๐ ๐ฝ๐ฟ๐ฒ๐๐๐๐ฟ๐ฒ?
Bamber wraps it up in style ๐คฉ
I cannot wait for Friday!
Match Centre ๐บ https://t.co/Df6Elex1Fl
๐ป#YouBears | #DURvWAR
๐ง๐ผ๐บ ๐๐ฎ๐๐ต๐ฎ๐บ ๐ถ๐ ๐ฎ ๐๐ฒ๐ฎ๐ฟ ๐ป
The New Zealand Test captain signs all formats for Warwickshire in 2025.
๐ป#YouBears | Read โฌ๏ธ
On the final day of the 2022 season, Warwickshire needed to beat Hampshire to stay in Division One.
Hampshire's fourth-innings target was just 139.
Liam Norwell took 9/62 and Warwickshire won by five runs.
I cannot believe this. NZ were 15 to one. They have done it again. This entire team should move to India.
Their first 3-0 in a three-Test series. Against a team that hadn't lost in 18 series.
What the hell were we watching here.
๐ฅ๐ฒ๐ฎ๐ฐ๐ต๐ถ๐ป๐ด ๐๐ต๐ฒ ๐ฆ๐ฒ๐บ๐ถ ๐๐ถ๐ป๐ฎ๏ฟฝ๏ฟฝ๏ฟฝ ๐ฆ๐๐๐ก๐๐ฆ! ๐คฉ
Kai Smith hits the winning runs much to the delight of teammates on the Bears balcony.
๐ป#YouBears | #WARvWOR
๐๐๐๐ฅ๐ฆ ๐๐ก๐ง๐ข ๐ฆ๐๐ ๐ ๐๐๐ก๐๐ ๐ฅณ๐ฅณ๐ฅณ
What a win... HOW GOOD WAS THAT!!!
We will face Glamorgan in Sunday's semi-final after a miraculous Edgbaston victory! ๐คฉ
๐ป#YouBears | #WARvWOR
@jfdwolff@kidney_boy@hswapnil @NeillDuncan3 Point of interest: VTE rates in nephrotic syndrome are influenced by type of GN (even after adjusting for age, S-Alb, cancer etc...) - membranous is particularly bad. Not entirely clear to me why (?filtration barrier's permeability to AT3 is different depending on site of injury)
Very well written account of how an excess of caution can contribute to absolutely pointless emergency episodes. Thank you. @acutemedicine
Much more advance care planning is required.
@NephMadness @jfnephlolz Also last minute sub of beyond KT/V to PD first paying dividends. Feel that I've been lucky to work in a couple of centres that are really strong on PD first and so it seems a bit second nature
Best ever R1 on #NephMadness - clearly having a UK contingent on the Blue Ribbon Panel has helped @jfnephlolz - surprised about Rapid Correction in Hyponatremia which I thought had the momentum with all the recent large observational studies #effluenteight
May 24th: Nephrology will get its fantastic fourth!
all in FLOW
all in Stockhom
all in @ERAkidney
Thanks, @VladoPerkovic and collaborators!
https://t.co/Lt7zKtcikE
KDIGO is pleased to announce the publication of the 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD).
Read the news release: https://t.co/kXzi5xxCvK
Download the guideline: https://t.co/wA8RRI90j9
Read the guideline in Kidney International: https://t.co/VHIZL34ls8
The KDIGO 2024 CKD Guideline was co-chaired by @adeeralevin and @KidneysRU. The Executive Summary will be published in the April 2024 issue of @Kidney_Int.
โWe are thrilled to publish this eagerly anticipated update, which comes during a transformative period in nephrology, offering new hope for people living with kidney disease," said Dr. Levin. โRecent advancements in GFR evaluation, risk prediction, and the arrival of novel treatments are poised to enhance CKD prognosis and management. We also hope the guidelineโs emphasis on multidisciplinary teamwork, patient engagement, and a holistic, evidence-based approach to care will help catalyze positive change, resulting in more coordinated CKD care management worldwide. By integrating the latest evidence and expert consensus, we aim to empower healthcare professionals, and patients with actionable recommendations to optimize patient outcomes and enhance quality of life.โ
โAs Co-Chairs, we would like to recognize the outstanding efforts of the Guideline Work Group and extend our thanks to the Evidence Review Team from Johns Hopkins, without whom this guideline would not have been possible," said Dr. Stevens. "The Work Group was diverse, multinational, highly experienced, and exceptionally committed, and we are grateful for their contributions to both this guideline and to global nephrology.โ